Publicaciones en colaboración con investigadores/as de AstraZeneca (United Kingdom) (19)

2024

  1. Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain

    Nefrologia, Vol. 44, Núm. 5, pp. 709-720

  2. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

    JAMA network open, Vol. 7, Núm. 4, pp. e247811

2023

  1. Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults

    Journal of Investigational Allergology and Clinical Immunology

2022

  1. Patient perspectives of the influence of severe and non-severe asthma on their quality of life: A national survey of asthma patients in Spain

    Clinical Respiratory Journal, Vol. 16, Núm. 2, pp. 130-141

2021

  1. DUART: Durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy

    Future Oncology, Vol. 17, Núm. 34, pp. 4657-4663

  2. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 1, pp. 51-65

  3. Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial

    European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  5. Real-world study in severe eosinophilic asthma patients refractory to anti-IL5 biological agents treated with benralizumab in Spain (ORBE study)

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

2020

  1. ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort

    Revista Espanola de Patologia, Vol. 53, Núm. 3, pp. 140-148

2017

  1. EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): A protocol of a European multicentre observational study

    BMJ Open, Vol. 7, Núm. 4

2014

  1. Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors

    Annals of Oncology, Vol. 25, Núm. 8, pp. 1656-1663

2012

  1. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study

    Multidisciplinary Respiratory Medicine, Vol. 7, Núm. 5

2011

  1. A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)

    Investigational New Drugs, Vol. 29, Núm. 5, pp. 1038-1044

2010

  1. Factors associated with asthma control in primary care patients: The CHAS study

    Archivos de Bronconeumologia, Vol. 46, Núm. 7, pp. 358-363

2008

  1. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia

    International Clinical Psychopharmacology, Vol. 23, Núm. 3, pp. 138-149

2006

  1. Micellization and drug solubilization in aqueous solutions of a diblock copolymer of ethylene oxide and phenyl glycidyl ether

    Langmuir, Vol. 22, Núm. 18, pp. 7465-7470

2005

  1. Block copolymers of ethylene oxide and phenyl glycidyl ether: Micellization, gelation, and drug solubilization

    Langmuir, Vol. 21, Núm. 12, pp. 5263-5271

1999

  1. A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex®) with intramuscular formestane in postmenopausal women with advanced breast cancer

    Annals of Oncology, Vol. 10, Núm. 10, pp. 1219-1225